NRC Health Total Liabilities
NRC Health (NRC) had Total Liabilities of $129.60 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-04
- 2026-06-30: Liabilities $129.60M.
- 2026-03-31: Liabilities $121.06M.
- 2025-12-31: Liabilities $120.89M.
- 2025-09-30: Liabilities $121.41M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $129.60M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $121.06M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $120.89M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $121.41M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $120.06M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $105.50M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $101.25M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $97.17M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $78.90M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $83.97M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $73.48M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $62.26M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $55.88M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $59.64M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $58.43M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $67.22M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $67.61M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $71.67M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $72.20M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $73.06M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $75.48M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $73.63M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $69.11M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $70.52M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $71.21M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $78.56M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $77.79M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $78.67M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $78.31M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $81.83M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $88.95M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $78.58M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $76.07M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $35.61M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $37.27M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $39.90M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $36.75M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $40.49M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $37.82M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $38.08M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $36.84M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $42.20M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $53.83M 10-K · filed 2017-03-03 | $54.88M 10-K · filed 2016-03-04 |
| 2015-09-30 | $42.89M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $41.35M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $40.61M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $41.76M 10-K · filed 2016-03-04 | |
| 2014-09-30 | $40.76M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $39.79M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $38.96M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $39.33M 10-K · filed 2015-03-04 | $39.24M 10-K · filed 2014-03-04 |
| 2013-09-30 | $42.38M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $41.66M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $43.55M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $43.30M 10-K · filed 2014-03-04 | |
| 2012-09-30 | $45.36M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $44.53M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $44.97M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $45.12M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $47.44M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $47.75M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $47.19M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |